Stay updated on Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.3 was added to the study's record history, indicating an updated page version. The older v3.6.0 tag was removed from the latest history listing.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history added new audit fields (Last verified and Last known status was) and marks the latest revision as v3.6.0; older audit labels (Verified, Last known status was:) and the earlier revision (v3.5.5) are removed from the current display.SummaryDifference2%

- Check34 days agoChange DetectedAn updated revision tag (v3.5.5) was added to the study history, replacing the previous v3.5.4. This reflects an updated record version in the metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history now shows the latest revision as v3.5.4, replacing v3.5.3. This reflects a small metadata update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision number was updated from v3.5.2 to v3.5.3, indicating a general platform/software revision rather than a change to the trial record details.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded last known status details and Poitiers University Hospital with date 2023-01 and verification; updated the revision to v3.5.2 and removed the previous v3.5.0.SummaryDifference0.9%

Stay in the know with updates to Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.